Literature DB >> 17669354

Purification and characterization of recombinant human liver glycolate oxidase.

Caroline Vignaud1, Nicolas Pietrancosta, Emma L Williams, Gill Rumsby, Florence Lederer.   

Abstract

Glycolate oxidase, an FMN-dependent peroxisomal oxidase, plays an important role in plants, related to photorespiration, and in animals, where it can contribute to the production of oxalate with formation of kidney stones. The best studied plant glycolate oxidase is that of spinach; it has been expressed as a recombinant enzyme, and its crystal structure is known. With respect to animals, the enzyme purified from pig liver has been characterized in detail in terms of activity and inhibition, the enzyme from human liver in less detail. We describe here the purification and initial characterization of the recombinant human glycolate oxidase. Its substrate specificity and the inhibitory effects of a number of anions are in agreement with the properties expected from previous work on glycolate oxidases from diverse sources. The recombinant enzyme presents an inhibition by excess glycolate and by excess DCIP, which has not been documented before. These inhibitions suggest that glycolate binds to the active site of the reduced enzyme, and that DCIP also has affinity for the oxidized enzyme. Glycolate oxidase belongs to a family of l-2-hydroxy-acid-oxidizing flavoenzymes, with strongly conserved active-site residues. A comparison of some of the present results with studies dealing with other family members suggests that residues outside the active site influence the binding of a number of ligands, in particular sulfite.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669354     DOI: 10.1016/j.abb.2007.06.021

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Experimental evidence for a hydride transfer mechanism in plant glycolate oxidase catalysis.

Authors:  Younès Dellero; Caroline Mauve; Edouard Boex-Fontvieille; Valérie Flesch; Mathieu Jossier; Guillaume Tcherkez; Michael Hodges
Journal:  J Biol Chem       Date:  2014-11-21       Impact factor: 5.157

2.  Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.

Authors:  Cristina Martin-Higueras; Sergio Luis-Lima; Eduardo Salido
Journal:  Mol Ther       Date:  2015-12-22       Impact factor: 11.454

3.  Structure of human glycolate oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole.

Authors:  Jean Marie Bourhis; Caroline Vignaud; Nicolas Pietrancosta; Françoise Guéritte; Daniel Guénard; Florence Lederer; Ylva Lindqvist
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

4.  Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design.

Authors:  Michael S Murray; Ross P Holmes; W Todd Lowther
Journal:  Biochemistry       Date:  2008-01-24       Impact factor: 3.162

5.  Involvement of ionizable groups in catalysis of human liver glycolate oxidase.

Authors:  Andrea Pennati; Giovanni Gadda
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

Review 6.  Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum.

Authors:  Ronald J A Wanders; Hans R Waterham; Sacha Ferdinandusse
Journal:  Front Cell Dev Biol       Date:  2016-01-28

7.  CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.

Authors:  Nerea Zabaleta; Miren Barberia; Cristina Martin-Higueras; Natalia Zapata-Linares; Isabel Betancor; Saray Rodriguez; Rebeca Martinez-Turrillas; Laura Torella; Africa Vales; Cristina Olagüe; Amaia Vilas-Zornoza; Laura Castro-Labrador; David Lara-Astiaso; Felipe Prosper; Eduardo Salido; Gloria Gonzalez-Aseguinolaza; Juan R Rodriguez-Madoz
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

8.  High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1.

Authors:  Mengqiao Wang; Miao Xu; Yan Long; Sonia Fargue; Noel Southall; Xin Hu; John C McKew; Christopher J Danpure; Wei Zheng
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.